STK26
MOLECULAR TARGETserine/threonine kinase 26
STK26 (serine/threonine kinase 26) is targeted by 30 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting STK26
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | tozasertib | 4.33 | 75 |
| 2 | ruxolitinib | 4.23 | 68 |
| 3 | bosutinib | 4.08 | 58 |
| 4 | dinaciclib | 3.87 | 47 |
| 5 | silmitasertib | 3.78 | 43 |
| 6 | neratinib | 3.66 | 38 |
| 7 | nintedanib | 3.61 | 36 |
| 8 | tae 684 | 3.43 | 30 |
| 9 | fedratinib | 3.40 | 29 |
| 10 | gilteritinib | 3.40 | 29 |
| 11 | linifanib | 3.33 | 27 |
| 12 | dovitinib | 3.09 | 21 |
| 13 | jnj 7706621 | 3.09 | 21 |
| 14 | lestaurtinib | 3.04 | 20 |
| 15 | pf 03758309 | 3.00 | 19 |
| 16 | danusertib | 2.94 | 18 |
| 17 | cediranib | 2.83 | 16 |
| 18 | pf 00562271 | 2.77 | 15 |
| 19 | hesperadin | 2.77 | 15 |
| 20 | pha 665752 | 2.71 | 14 |
| 21 | crenolanib | 2.71 | 14 |
| 22 | kw 2449 | 2.64 | 13 |
| 23 | gsk 690693 | 2.64 | 13 |
| 24 | su 014813 | 2.20 | 8 |
| 25 | decernotinib | 2.20 | 8 |
| 26 | cyc 116 | 2.08 | 7 |
| 27 | enzastaurin | 2.08 | 7 |
| 28 | amg 900 | 2.08 | 7 |
| 29 | Crizotinib | 0.69 | 1 |
| 30 | Dasatinib | 0.69 | 1 |
About STK26 as a Drug Target
STK26 (serine/threonine kinase 26) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 30 compounds with documented STK26 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
STK26 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.